Clinical Trial

A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines

Study acronym: RICHER
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study will serve to collect and analyze additional data on the use of the device croma revitalis for treatment of fine lines on the face including LCL and PR in the routine practice and as "real-world" performance.
Protocol Amendment History 3 changes
critical Enrollment closed, study ongoing 2026-07-29
notable Primary completion moved earlier: 2026-07-15 -> 2026-06-09 2026-07-29
minor Completion moved earlier: 2026-11-15 -> 2026-09 2026-07-29
Trial Details
NCT Number NCT07492277
Lead Sponsor Croma-Pharma GmbH
Conditions Lateral Canthal Lines (LCL), Perioral Rhytids
Enrollment 70 participants
Start Date 2026-01-16
Primary Completion 2026-06-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-28